Monomethyl Fumarate
HIV Infection
Fred Hutchinson Cancer CenterSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
23 Active assets in the HIV Infection cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE AIDS Malignancy Consortium | Phase 2 | BBB |
Lamivudine José Antonio Mata Marín | Phase 4 | BBB |
PREDNISONE TABLETS City of Hope Medical Center | Phase 2 | BB |
Metformin Brigham and Women's Hospital | Phase 4 | BB |
Cyclophosphamide AIDS Malignancy Consortium | Phase 3 | BB |
View all 50 →
Same molecule, other indications
Monomethyl Fumarate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →